Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting | Zendy

AI Assistant Blog Pricing

Open Access

Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting

Author(s) -

Rocco Totaro,

Gianfranco Costantino,

P. Bellantonio

Publication year - 2015

Publication title -

journal of neurology and neurophysiology

Language(s) - English

Resource type - Journals

ISSN - 2155-9562

DOI - 10.4172/2155-9562.1000337

Subject(s) - natalizumab , fingolimod , multiple sclerosis , relapsing remitting , medicine , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.